Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin
详细信息 查看全文
- 作者：Honghai Hong (1)
Ti Zhou (1)
Shuhuan Fang (2)
Minghan Jia (1)
Zumin Xu (3)
Zhiyu Dai (1)
Cen Li (1)
Shuai Li (1)
Lei Li (4)
Ting Zhang (1)
Weiwei Qi (1)
Adham Sameer A. Bardeesi (1) (2) (3) (4) (5) (6)
Zhonghan Yang (1)
Weibin Cai (1)
Xia Yang (1) (5)
Guoquan Gao (1) (6) - 关键词：Pigment epithelium ; derived factor ; Metastasis ; Laminin receptor ; Fibronetin ; MMP ; 2 ; MMP ; 9
- 刊名：Breast Cancer Research and Treatment
- 出版年：2014
- 出版时间：November 2014
- 年：2014
- 卷：148
- 期：1
- 页码：61-72
- 全文大小：2,823 KB
- 参考文献：1. Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69鈥?0 CrossRef
2. Weigelt B, Peterse JL, van鈥檛 Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5(8):591鈥?02 CrossRef
3. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127(4):679鈥?95 CrossRef
4. Fernandez-Garcia B et al (2014) Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology 64(4):512鈥?22 CrossRef
5. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285(5430):1028鈥?032 CrossRef
6. Hynes RO (1994) Genetic analyses of cell-matrix interactions in development. Curr Opin Genet Dev 4(4):569鈥?74 CrossRef
7. Ioachim E et al (2002) Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 38(18):2362鈥?370 CrossRef
8. Bae YK et al (2013) Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. Hum Pathol 44(10):2028鈥?037 CrossRef
9. Mitra AK et al (2011) Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30(13):1566鈥?576 CrossRef
10. Malik G et al (2010) Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res 70(11):4327鈥?334 CrossRef
11. Shibata K et al (1998) Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res 58(5):900鈥?03
12. Das S et al (2008) Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 82(9鈥?0):467鈥?76 CrossRef
13. Maity G et al (2011) Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol 32(1):129鈥?38 CrossRef
14. Becerra SP (2006) Focus on molecules: pigment epithelium-derived factor (PEDF). Exp Eye Res 82(5):739鈥?40 CrossRef
15. Steele FR et al (1993) Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A 90(4):1526鈥?530 CrossRef
16. Tombran-Tink J, Johnson LV (1989) Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 30(8):1700鈥?707
17. Bilak MM et al (1999) Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 58(7):719鈥?28 CrossRef
18. Kuncl RW et al (2002) Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J Neurochem 81(1):178鈥?84 CrossRef
19. Sawant S et al (2004) Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun 325(2):408鈥?13 CrossRef
20. Uehara H et al (2004) Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 64(10):3533鈥?537 CrossRef
21. Alberdi E, Hyde CC, Becerra SP (1998) Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry 37(30):10643鈥?0652 CrossRef
22. Filleur S et al (2009) Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem 106(5):769鈥?75 CrossRef
23. Bouck N (2002) PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 8(7):330鈥?34 CrossRef
24. Broadhead ML, Dass CR, Choong PF (2009) In vitro and in vivo biological activity of PEDF against a range of tumors. Expert Opin Ther Targets 13(12):1429鈥?438 CrossRef
25. Hoshina D et al (2010) The role of PEDF in tumor growth and metastasis. Curr Mol Med 10(3):292鈥?95 CrossRef
26. Ek ET et al (2007) Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther 14(7):616鈥?26 CrossRef
27. Ek ET et al (2007) Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin Exp Metastasis 24(2):93鈥?06 CrossRef
28. Orgaz JL et al (2009) Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma. Oncogene 28(47):4147鈥?161 CrossRef
29. Lattier JM et al (2013) Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma. Clin Exp Metastasis 30(8):969鈥?76 CrossRef
30. Guan M et al (2004) Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11(5):325鈥?32 CrossRef
31. Jan R, Huang M, Lewis-Wambi J (2012) Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer. Breast Cancer Res 14(6):R146 CrossRef
32. Cai J et al (2006) Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin Cancer Res 12(11 Pt 1):3510鈥?517 CrossRef
33. Zhou D et al (2010) Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. J Cancer Res Clin Oncol 136(11):1719鈥?727 CrossRef
34. Fitzgerald DP et al (2012) Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage. Cancer Res 72(1):144鈥?53 CrossRef
35. Cai WB et al (2012) Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1alpha pathway. PLoS One 7(12):e53152 CrossRef
36. Yasuoka H et al (2009) The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms. Am J Pathol 175(2):605鈥?15 CrossRef
37. Hua P et al (2012) The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells. Am J Physiol Renal Physiol 302(11):F1418鈥揊1429 CrossRef
38. Bernard A et al (2009) Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol Chem 284(16):10480鈥?0490 CrossRef
39. Park K et al (2011) Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol 31(14):3038鈥?051 CrossRef
40. Notari L et al (2006) Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J Biol Chem 281(49):38022鈥?8037 CrossRef
41. Ek ET, Dass CR, Choong PF (2006) PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 12(10):497鈥?02 CrossRef
42. Abe R et al (2004) Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164(4):1225鈥?232 CrossRef
43. Takenaka K et al (2005) Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77(25):3231鈥?241 CrossRef
44. Drasin DJ, Robin TP, Ford HL (2011) Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res 13(6):226 CrossRef
45. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131鈥?42 CrossRef
46. Palena C et al (2011) Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Exp Biol Med (Maywood) 236(5):537鈥?45 CrossRef
47. Wang JJ et al (2006) Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes 55(6):1678鈥?685 CrossRef
48. Notari L et al (2005) Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 46(8):2736鈥?747 CrossRef
49. Saini KS et al (2013) Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev 39(8):935鈥?46 CrossRef
50. Aksamitiene E, Kiyatkin A, Kholodenko BN (2012) Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Biochem Soc Trans 40(1):139鈥?46 CrossRef
51. Serra V et al (2011) PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene 30(22):2547鈥?557 CrossRef
52. Becerra SP, Notario V (2013) The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat Rev Cancer 13(4):258鈥?71 CrossRef
53. Menard S, Tagliabue E, Colnaghi MI (1998) The 67聽kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 52(1鈥?):137鈥?45 CrossRef
54. Kondo A et al (2013) Epigallocatechin-3-gallate potentiates curcumin鈥檚 ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis. Int J Clin Oncol 18(3):380鈥?88 CrossRef
55. Duan SG et al (2010) The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells. Dig Dis Sci 55(10):2844鈥?852 CrossRef - 作者单位：Honghai Hong (1)
Ti Zhou (1)
Shuhuan Fang (2)
Minghan Jia (1)
Zumin Xu (3)
Zhiyu Dai (1)
Cen Li (1)
Shuai Li (1)
Lei Li (4)
Ting Zhang (1)
Weiwei Qi (1)
Adham Sameer A. Bardeesi (1) (2) (3) (4) (5) (6)
Zhonghan Yang (1)
Weibin Cai (1)
Xia Yang (1) (5)
Guoquan Gao (1) (6)
1. Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, 74 Zhongshan Road II, Guangzhou, 510080, Guangdong, China
2. DME Center, Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China
3. Cancer Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang, 524000, China
4. Key Laboratory for Reproductive Medicine of Guangdong Province, Department of Reproductive Medicine Center, Third Affiliated Hospital of Guangzhou Medical University, 63 Duobao Road, Guangzhou, China
5. China Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-sen University, Guangzhou, 510080, China
6. Key Laboratory of Functional Molecules from Marine Microorganisms, Department of Education of Guangdong Province, Sun Yat-sen University, Guangzhou, China - ISSN：1573-7217
文摘
Pigment epithelium-derived factor (PEDF) plays an important role in the tumor growth and metastasis inhibition. It has been reported that PEDF expression is significantly reduced in breast cancer, and associated with disease progression and poor patient outcome. However, the exact mechanism of PEDF on breast cancer metastasis including liver and lung metastasis remains unclear. The present study aims to reveal the impact of PEDF on breast cancer. The orthotopic tumor mice model inoculated by MDA-MB-231 cells stably expressing PEDF or control cells was used to assess liver and lung metastasis of breast cancer. In vitro, migration and invasion experiments were used to detect the metastatic abilities of MDA-MB-231 and SKBR3 breast cancer cells with or without overexpression of PEDF. The metastatic-related molecules including EMT makers, fibronectin, and p-AKT and p-ERK were detected by qRT-PCR, Western blot, and Fluorescent immunocytochemistry. PEDF significantly inhibited breast cancer growth and metastasis in vivo and in vitro. Mechanically, PEDF inhibited breast cancer cell migration and invasion by down-regulating fibronectin and subsequent MMP2/MMP9 reduction via p-ERK and p-AKT signaling pathways. However, PEDF had no effect on EMT conversion in the breast cancer cells which was usually involved in cancer metastasis. Furthermore, the study showed that laminin receptor mediated the down-regulation of fibronectin by PEDF. These results reported for the first time that PEDF inhibited breast cancer metastasis by down-regulating fibronectin via laminin receptor/AKT/ERK pathway. Our findings demonstrated PEDF as a dual effector in limiting breast cancer growth and metastasis and highlighted a new avenue to block breast cancer progression.